$OKLO

Narayanadas Vivek sold $16K of OKLO

Narayanadas Vivek (General Counsel & Secretary) sold 365 shares of Oklo Inc. (OKLO) at $43.31 on 2026-09-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Narayanadas Vivek
Published Sep 10, 2026, 8:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 8:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OKLO
Neutral
high confidence
Mentioned
$OKLO
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

The sale is pre‑arranged and modest; market impact is expected to be negligible.

02

Market read

A routine insider transaction with limited trading relevance.

03

What to watch

Potential future insider transactions or larger holdings changes not disclosed here.

Relevance 2/10Novelty 4/10Timing: filed Sep 10, 2026

Background

SEC Form 4 filing discloses an insider sale by Oklo Inc.'s General Counsel.

Company-level read

Ticker impact

$OKLONeutralHigh confidence
Context

General Counsel Narayanadas Vivek sold 365 shares for $15,808.15 via a 10b5‑1 plan on Sep 9, 2026.

Expected impact

No significant price impact expected.

Evidence & confidence

The transaction size ($16K) is trivial relative to market cap and was pre‑arranged under a 10b5‑1 plan.

Market effects

None

None

None

Counterpoint

Insider sell could signal undisclosed concerns, but size is too small to act on.

Key entities

  • Oklo Inc.

    Uranium mining and nuclear fuel company listed on NYSE under ticker OKLO.

  • Narayanadas Vivek

    General Counsel & Secretary of Oklo, reporting officer in the Form 4.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OKLOMed

UBS cuts Oklo stock price target to $41 on estimate updates

UBS reduced its price target for Oklo Inc. (NYSE:OKLO) to $41 from $55, citing updated estimates and maintaining a Neutral rating. The stock is down 68% over the past year. Oklo reported a wider-than-expected Q2 2026 loss but exceeded revenue forecasts, with $3.0 billion in cash. The company launched a $1 billion stock offering program. UBS and Truist Securities highlight near-term execution risks and progress in projects.

$OKLOMedAI 8/10

OKLO, XE Stocks Jump After-Hours — Trump Administration Taps Oklo, X-Energy In $200M Push To Power AI Data Centers

Oklo Inc. (OKLO) and X-Energy Inc. (XE) gained in after-hours trading after joining a $200M federal initiative to build nuclear power plants for AI data centers. The program includes Microsoft (MSFT) and Nvidia (NVDA), with $60M allocated to labs and universities. The initiative aims to accelerate reactor construction and reduce staffing needs, addressing rising electricity demand and grid strain.

$OKLOHigh

Nuclear Stocks Oklo, NuScale Power, and X

Shares of Oklo (OKLO), NuScale Power (SMR), and X-Energy (XE) surged after the U.S. House passed the Ratepayer Protection Act, which may boost demand for their small modular reactors as data center power sources. XE stock rose 12.08% to $16.33. Analysts see 106% upside for XE, with a $33.71 average price target.